Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. - Wikidata - wikimedia - TriplyDB

Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction.

Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction.

http://www.wikidata.org/entity/Q36522680

about

CXCL10 Is a Circulating Inflammatory Marker in Patients with Advanced Heart Failure: a Pilot Study.MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death.Interleukin-17A contributes to the development of post-operative atrial fibrillation by regulating inflammation and fibrosis in rats with sterile pericarditis.Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction.Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells.The role of antioxidation and immunomodulation in postnatal multipotent stem cell-mediated cardiac repair.Naoxintong attenuates Ischaemia/reperfusion Injury through inhibiting NLRP3 inflammasome activation.Cyclosporin A in left ventricular remodeling after myocardial infarction.Vγ1⁺ γδT Cells Are Correlated With Increasing Expression of Eosinophil Cationic Protein and Metalloproteinase-7 in Chronic Rhinosinusitis With Nasal Polyps Inducing the Formation of Edema.Mesenchymal stem cell therapy for cardiac inflammation: immunomodulatory properties and the influence of toll-like receptors.The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.Cytokine Effects on Mechano-Induced Electrical Activity in Atrial Myocardium.The proton-sensing G protein-coupled receptor T-cell death-associated gene 8 (TDAG8) shows cardioprotective effects against myocardial infarction.RORγt-expressing cells attenuate cardiac remodeling after myocardial infarction.A carvedilol-responsive microRNA, miR-125b-5p protects the heart from acute myocardial infarction by repressing pro-apoptotic bak1 and klf13 in cardiomyocytes.Anti-inflammatory therapies in myocardial infarction: failures, hopes, and challenges.The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies?T-cells in myocardial infarction: Culprit instigators or mere effectors?Liver-heart crosstalk controls IL-22 activity in cardiac protection after myocardial infarction Association of levels of interleukin 17 and T-helper 17 count with symptom severity and etiology of chronic heart failure: a case-control study

P2860

Q34529921-863A7BFB-67B6-4119-95C1-DFACFCB975F3 Q35661827-97FA63FB-FADC-4EFF-9DC6-7EB0E0DE0B1A Q35827568-421B8400-74C8-43AC-873B-33A228A59E34 Q36030025-04BDB7A5-DC44-410B-9CF8-478FFB4A04A0 Q36814572-7777B8A9-FC81-4AE4-A381-73B942BED341 Q37139158-7F237B7A-93F1-4C55-AD22-18609938C7AA Q37539910-213A6215-6923-40D5-94DA-EFA8A736DBAB Q37575962-76AC0BCC-1AF8-4549-955E-62F4A0906156 Q37606280-EB3A81F1-1A70-44D5-8EB8-1F1144E139BE Q38175951-41D53640-5319-4B68-8ECD-137905846CA0 Q38875774-0B55705D-50F4-402B-BCD9-D06568523310 Q38951853-D43E13E9-7426-4385-9D47-B64C2B522F08 Q41352801-4907C3A5-66F9-4CE8-AF1E-FD7F823DA1DD Q41475326-FCE3BEF2-6CDB-4601-ACE4-8068BCCD644C Q47419808-8461CF40-E1C1-48B4-8DF9-87DCBACAE581 Q48113765-1DE3F496-DB17-46F2-8CE9-9C45D2E3B653 Q52729626-0195B1BB-D556-410C-A7AE-213F39CA0AD9 Q58551459-EA85AA42-9CA9-44D9-9945-4BB49CABB12E Q58788939-04045025-4A01-4A49-830C-AE6E0F497D66 Q58804329-A903E7E3-9639-46EF-A63D-3D2E8FB1C162

P2860

Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction.

http://www.wikidata.org/entity/Q36522680

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@ast

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@en

type

label

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@ast

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@en

prefLabel

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@ast

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@en

P1433

Q36522680-C81A77A0-013D-4CA7-831A-2F952F8613C7

P1476

Q36522680-D75CA367-4451-4914-8B7C-83516EDF9EA4

P2093

Q36522680-0B00426F-7D6B-4351-AFAF-28CF0560F168

Q36522680-289BD2F2-C3C9-4820-9831-7F4A615DCC00

Q36522680-388BBDA3-E4CE-4E0E-AD23-258A554D0B5D

Q36522680-3A19F6A3-EECF-4756-A9D1-04454E5D0CC2

Q36522680-47AA397D-31F8-477B-936B-45D2E3713D49

Q36522680-586484DB-33D5-423E-B7CD-5D5AE756BC6A

Q36522680-6F5098C6-25E5-491E-86C3-C3DCDC227098

Q36522680-7D6A1BE4-94DE-4C15-A026-E66A85FF9503

Q36522680-841542F2-D754-4846-8AE2-ABA723522843

Q36522680-92693D23-AE5C-442D-8AF9-CF8FE5475FD5

P2860

Q36522680-007ED497-BB18-4E03-9DF3-395280390E84

Q36522680-09F2B9F0-4998-4835-9EE8-568A5235CA95

Q36522680-0C908ABD-96B7-4890-B8EE-B94CCB54D499

Q36522680-0DA5E2E6-5875-4A1D-9AE6-3C2FE1F960BF

Q36522680-0E335E96-A0DE-4DA7-A07C-92F49D6CB8E2

Q36522680-148A6519-9A4E-4FC5-A963-73A9F2A6891B

Q36522680-2314AFC1-61B2-46BF-A949-6B223EF7B5E4

Q36522680-262F20C6-9C02-4725-BBF1-60D34A91FC8B

Q36522680-2711A3B0-77B3-4C6E-AE20-2E2B59B7825D

Q36522680-2D5B6C35-9CB5-4648-8943-C21A4DA444B6

P304

Q36522680-EDDA47EF-D999-403E-978B-E5EB699511D9

P31

Q36522680-1FACBFD5-D80A-44D4-92D9-C6031F3C1366

P356

Q36522680-F4D8DB81-3A86-45A3-A1DB-FBC0CB87DCE9

P433

Q36522680-948C5F3E-77B1-4F96-A8AC-6DB9610FC581

P478

Q36522680-4F4282D1-254B-43D5-8FFB-1FBD368E7A75

P577

Q36522680-65E9AAC5-5C7C-4557-9629-DE6C46D4A1BB

P698

Q36522680-8B8D6C05-0EB6-45BD-BBEF-8C45EA1EA5EC

P932

Q36522680-30C294CE-2141-4756-B784-21987B9AF31D

P356

JAHA.112.004408

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Deleterious effect of the IL-2 ...... g after myocardial infarction.

@en

P2093

Akihiko Yoshimura

http://www.w3.org/2001/XMLSchema#string

Atsushi Anzai

http://www.w3.org/2001/XMLSchema#string

Hideyuki Ito

http://www.w3.org/2001/XMLSchema#string

Jin Endo

http://www.w3.org/2001/XMLSchema#string

Jun Fujita

http://www.w3.org/2001/XMLSchema#string

Keiichi Fukuda

http://www.w3.org/2001/XMLSchema#string

Ken Shinmura

http://www.w3.org/2001/XMLSchema#string

Kensuke Kimura

http://www.w3.org/2001/XMLSchema#string

Kentaro Ito

http://www.w3.org/2001/XMLSchema#string

Motoaki Sano

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)

Heart disease and stroke statistics--2012 update: a report from the American Heart Association

Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Inflammasomes in health and disease

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.

IL-17 regulates CXCL1 mRNA stability via an AUUUA/tristetraprolin-independent sequence.

Monocytes: protagonists of infarct inflammation and repair after myocardial infarction

Functional specialization of interleukin-17 family members.

DAMPening inflammation by modulating TLR signalling.

P304

e004408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/JAHA.112.004408

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2012-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23316306

http://www.w3.org/2001/XMLSchema#string

P932

3541626

http://www.w3.org/2001/XMLSchema#string